Important Message IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON MEDTECH SYNDICATES ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
MedTechSyndicates.com is owned and operated by MedTech Syndicates LLC (“MTS”). MTS is not a registered Broker-Dealer, funding portal or investment adviser. MTS does not offer or sell securities, solicit or accept investments, make investment recommendations, or hold or handle investor funds or securities.
All securities offerings referenced on this site are conducted solely by ICON Capital Group, LLC (“ICON”), a Broker-Dealer registered with the SEC and a member of FINRA and SIPC (CRD #4029), unless a specific offering page names a different intermediary. ICON and MTS are not affiliated and have no common ownership. Check the background of ICON and its registered representatives on FINRA BrokerCheck.
MTS is compensated with a fixed fee paid by ICON, not based on whether any offering succeeds or on the amount that any investor invests. See our Compensation Disclosure.
Offerings referenced on this site may be made under: (1) Regulation A (Tier 1 or Tier 2), open to accredited and non-accredited investors, subject to investment limits for non-accredited investors in Tier 2; (2) Regulation D Rule 506(c), open only to verified accredited investors; and (3) Regulation Crowdfunding, open to all investors subject to annual investment limits for non-accredited investors. Each offering is conducted by ICON, which acts as broker-dealer or, for Reg CF, as the registered intermediary.
Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. MTS does not provide investment, legal or tax advice, and nothing on this site is a recommendation to buy any security. Information about each issuer is provided by that issuer, which is responsible for it. Clinician commentary, KOL participation and MTS’s review of companies are not an endorsement or an assessment of investment merit. ICON performs due diligence on offerings it conducts as required by FINRA rules; that review does not guarantee accuracy or performance. Neither Medtech Syndicates nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.
Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. Securities offered under Reg CF and Reg D are restricted and generally cannot be resold for at least one year (Reg CF) or without registration or an exemption (Reg D). See additional general disclosures here.
By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.